Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

CTCX

Carmell Corp

May 01 • 04:00PM ET

2.05

Dollar change +0.05
Percentage change 2.50	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.56	Insider Own	30.36%	Shs Outstand	23.09M	Perf Week	-6.82%
Market Cap	42.50M	Forward P/E	-	EPS next Y	-	Insider Trans	1.01%	Shs Float	14.44M	Perf Month	-18.00%
Income	-10.38M	PEG	-	EPS next Q	-	Inst Own	17.73%	Short Float	0.16%	Perf Quarter	-39.88%
Sales	3.73M	P/S	11.39	EPS this Y	-	Inst Trans	5.40%	Short Ratio	3.47	Perf Half Y	0.26%
Book/sh	0.91	P/B	2.26	EPS next Y	-	ROA	-8.68%	Short Interest	0.02M	Perf Year	-79.74%
Cash/sh	0.38	P/C	5.33	EPS next 5Y	-	ROE	-12.12%	52W Range	1.70 - 13.31	Perf YTD	-46.19%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-44.83%	52W High	-84.60%	Beta	0.41
Dividend TTM	-	Quick Ratio	0.77	Sales past 5Y	0.00%	Gross Margin	47.08%	52W Low	20.59%	ATR (14)	0.28
Dividend Ex-Date	-	Current Ratio	1.03	EPS Y/Y TTM	-4023.53%	Oper. Margin	-188.68%	RSI (14)	40.57	Volatility	12.69% 11.28%
Employees	10	Debt/Eq	0.46	Sales Y/Y TTM	-	Profit Margin	-278.42%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.11	EPS Q/Q	-1554.12%	Payout	-	Rel Volume	0.65	Prev Close	2.00
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	6.78K	Price	2.05
SMA20	-12.63%	SMA50	-22.27%	SMA200	-40.73%	Trades		Volume	4,419	Change	2.50%

Apr-11-24 04:30PM	Carmell Announces Successful Closing of $3.0 Million Private Placement (GlobeNewswire) -5.60%
Apr-04-24 08:30AM	Carmell Announces $3.0 Million Private Placement (GlobeNewswire) -9.72%
Mar-27-24 09:15AM	Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction (GlobeNewswire) -11.03%
Mar-20-24 04:39PM	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary (GlobeNewswire) +11.84%
Mar-18-24 03:16PM	Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field (GlobeNewswire)
08:30AM	Loading…
Feb-26-24 08:30AM	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 (GlobeNewswire) +28.92%
Nov-16-23 08:30AM	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors (GlobeNewswire)
Sep-12-23 12:35PM	Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine (PR Newswire)
Sep-05-23 06:03PM	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics (GlobeNewswire) +17.60%
Aug-09-23 03:41PM	Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity (Business Wire)
Jul-27-23 07:00AM	Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (Business Wire) +46.00%

Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gregory Kathryn	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:10 PM
Anderson David W	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:10 PM
Sturgeon Patrick A	Director	Dec 15 '23	Buy	3.94	739	2,908	6,727	Dec 18 05:11 PM
Spenlehauer Gilles	Director	Dec 15 '23	Buy	3.94	591	2,326	5,381	Dec 18 05:13 PM
Frisch Scott M.	Director	Dec 15 '23	Buy	3.94	591	2,326	5,381	Dec 18 05:12 PM
Cassaday Bryan J.	Chief Financial Officer	Dec 14 '23	Buy	3.50	440	1,540	1,940	Dec 19 05:00 PM
Anderson David W	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:10 PM
Gregory Kathryn	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:10 PM
Sturgeon Patrick A	Director	Dec 14 '23	Buy	3.61	391	1,412	5,988	Dec 18 05:11 PM
Frisch Scott M.	Director	Dec 14 '23	Buy	3.61	313	1,131	4,790	Dec 18 05:12 PM
Spenlehauer Gilles	Director	Dec 14 '23	Buy	3.61	313	1,131	4,790	Dec 18 05:13 PM
Upton Richard A	Director	Dec 13 '23	Buy	3.47	2,400	8,330	4,400	Dec 13 09:53 PM
Anderson David W	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:36 PM
Gregory Kathryn	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:36 PM
Sturgeon Patrick A	Director	Dec 13 '23	Buy	5.57	1,087	6,056	5,597	Dec 13 09:48 PM
Frisch Scott M.	Director	Dec 13 '23	Buy	5.57	869	4,841	4,477	Dec 13 09:38 PM
Spenlehauer Gilles	Director	Dec 13 '23	Buy	5.57	869	4,841	4,477	Dec 13 09:37 PM
Upton Richard A	Director	Dec 12 '23	Buy	3.50	2,000	7,000	2,000	Dec 13 09:53 PM
Anderson David W	Director	Dec 12 '23	Buy	3.50	1,087	3,806	4,510	Dec 13 09:36 PM
Gregory Kathryn	Director	Dec 12 '23	Buy	3.50	1,087	3,806	4,510	Dec 13 09:36 PM
Sturgeon Patrick A	Director	Dec 12 '23	Buy	3.50	1,087	3,806	4,510	Dec 13 09:48 PM
Frisch Scott M.	Director	Dec 12 '23	Buy	3.50	869	3,043	3,608	Dec 13 09:38 PM
Spenlehauer Gilles	Director	Dec 12 '23	Buy	3.50	869	3,043	3,608	Dec 13 09:37 PM
Anderson David W	Director	Dec 11 '23	Buy	3.53	1,087	3,834	3,423	Dec 13 09:36 PM
Gregory Kathryn	Director	Dec 11 '23	Buy	3.53	1,087	3,834	3,423	Dec 13 09:36 PM
Sturgeon Patrick A	Director	Dec 11 '23	Buy	3.53	1,087	3,834	3,423	Dec 13 09:48 PM
Frisch Scott M.	Director	Dec 11 '23	Buy	3.53	870	3,069	2,739	Dec 13 09:38 PM
Spenlehauer Gilles	Director	Dec 11 '23	Buy	3.53	870	3,069	2,739	Dec 13 09:37 PM
Sturgeon Patrick A	Director	Dec 08 '23	Buy	3.15	46	145	2,336	Dec 08 09:15 PM
Anderson David W	Director	Dec 08 '23	Buy	3.15	46	145	2,336	Dec 08 09:19 PM
Gregory Kathryn	Director	Dec 08 '23	Buy	3.15	46	145	2,336	Dec 08 09:14 PM
Frisch Scott M.	Director	Dec 08 '23	Buy	3.15	36	113	1,869	Dec 08 09:08 PM
Spenlehauer Gilles	Director	Dec 08 '23	Buy	3.15	36	113	1,869	Dec 08 09:12 PM
Anderson David W	Director	Dec 07 '23	Buy	3.07	248	760	2,290	Dec 08 09:19 PM
Gregory Kathryn	Director	Dec 07 '23	Buy	3.07	248	760	2,290	Dec 08 09:14 PM
Sturgeon Patrick A	Director	Dec 07 '23	Buy	3.07	248	760	2,290	Dec 08 09:15 PM
Spenlehauer Gilles	Director	Dec 07 '23	Buy	3.07	199	610	1,833	Dec 08 09:12 PM
Frisch Scott M.	Director	Dec 07 '23	Buy	3.07	199	610	1,833	Dec 08 09:08 PM
Anderson David W	Director	Dec 06 '23	Buy	3.03	608	1,844	2,042	Dec 08 09:19 PM
Sturgeon Patrick A	Director	Dec 06 '23	Buy	3.03	608	1,844	2,042	Dec 08 09:15 PM
Gregory Kathryn	Director	Dec 06 '23	Buy	3.03	608	1,844	2,042	Dec 08 09:14 PM
Frisch Scott M.	Director	Dec 06 '23	Buy	3.03	487	1,477	1,634	Dec 08 09:08 PM
Spenlehauer Gilles	Director	Dec 06 '23	Buy	3.03	487	1,477	1,634	Dec 08 09:12 PM
Anderson David W	Director	Dec 05 '23	Buy	3.10	347	1,077	1,434	Dec 08 09:19 PM
Gregory Kathryn	Director	Dec 05 '23	Buy	3.10	347	1,077	1,434	Dec 08 09:14 PM
Sturgeon Patrick A	Director	Dec 05 '23	Buy	3.10	347	1,077	1,434	Dec 08 09:15 PM
Spenlehauer Gilles	Director	Dec 05 '23	Buy	3.10	277	860	1,147	Dec 08 09:12 PM
Frisch Scott M.	Director	Dec 05 '23	Buy	3.10	277	860	1,147	Dec 08 09:08 PM
Anderson David W	Director	Dec 04 '23	Buy	3.00	1,087	3,259	1,087	Dec 08 09:19 PM
Sturgeon Patrick A	Director	Dec 04 '23	Buy	3.00	1,087	3,259	1,087	Dec 08 09:15 PM
Gregory Kathryn	Director	Dec 04 '23	Buy	3.00	1,087	3,259	1,087	Dec 08 09:14 PM
Frisch Scott M.	Director	Dec 04 '23	Buy	3.00	870	2,609	870	Dec 08 09:08 PM
Spenlehauer Gilles	Director	Dec 04 '23	Buy	3.00	870	2,609	870	Dec 08 09:12 PM
Shukla Rajiv	Chairman and CEO	Dec 01 '23	Buy	2.50	502	1,255	34,179	Dec 04 09:55 PM
Shukla Rajiv	Chairman and CEO	Nov 30 '23	Buy	2.66	5,600	14,917	33,677	Dec 04 09:55 PM
Shukla Rajiv	Chairman and CEO	Nov 29 '23	Buy	2.91	5,014	14,578	28,077	Dec 04 09:55 PM
Shukla Rajiv	Chairman and CEO	Nov 28 '23	Buy	2.92	2,501	7,303	23,063	Dec 04 09:55 PM
Cassaday Bryan J.	Chief Financial Officer	Nov 28 '23	Buy	2.85	1,500	4,275	1,500	Nov 30 08:32 PM
Shukla Rajiv	Chairman and CEO	Nov 27 '23	Buy	2.97	2,100	6,247	20,562	Nov 28 06:12 PM
Shukla Rajiv	Chairman and CEO	Nov 24 '23	Buy	2.95	2,715	7,999	18,462	Nov 28 06:12 PM
Shukla Rajiv	Chairman and CEO	Nov 22 '23	Buy	2.78	1,185	3,291	15,747	Nov 28 06:12 PM
Shukla Rajiv	Chairman and CEO	Nov 21 '23	Buy	2.49	200	497	14,562	Nov 21 09:01 PM
Shukla Rajiv	Chairman and CEO	Nov 20 '23	Buy	2.62	3,750	9,817	14,362	Nov 21 09:01 PM
Shukla Rajiv	Chairman and CEO	Nov 17 '23	Buy	2.69	2,000	5,380	10,612	Nov 21 09:01 PM
Shukla Rajiv	Executive Chairman	Aug 28 '23	Buy	3.50	2,100	7,343	8,612	Aug 31 04:01 PM
Hubbell Randolph W	President and CEO	Aug 28 '23	Buy	3.49	100	349	2,750	Aug 30 09:52 PM
Shukla Rajiv	Executive Chairman	Aug 25 '23	Buy	3.50	600	2,100	6,512	Aug 31 04:01 PM
Hubbell Randolph W	President and CEO	Aug 25 '23	Buy	3.50	200	700	2,650	Aug 30 09:52 PM
Shukla Rajiv	Executive Chairman	Aug 24 '23	Buy	3.50	500	1,750	5,912	Aug 31 04:01 PM
Hubbell Randolph W	President and CEO	Aug 24 '23	Buy	3.57	200	714	2,450	Aug 30 09:52 PM
Hubbell Randolph W	President and CEO	Aug 23 '23	Buy	3.60	200	721	2,250	Aug 30 09:52 PM
Hubbell Randolph W	President and CEO	Aug 22 '23	Buy	3.51	100	351	2,050	Aug 30 09:52 PM
Hubbell Randolph W	President and CEO	Aug 21 '23	Buy	3.67	300	1,100	1,950	Aug 30 09:52 PM
Shukla Rajiv	Executive Chairman	Aug 21 '23	Buy	3.54	100	354	5,412	Aug 31 04:01 PM
Shukla Rajiv	Executive Chairman	Aug 18 '23	Buy	3.62	4,100	14,825	5,312	Aug 31 04:01 PM
Hubbell Randolph W	President and CEO	Aug 18 '23	Buy	3.73	1,200	4,482	1,650	Aug 30 09:52 PM
Hubbell Randolph W	President and CEO	Aug 17 '23	Buy	3.72	450	1,674	450	Aug 30 09:52 PM
Shukla Rajiv	Executive Chairman	Aug 17 '23	Buy	3.54	100	354	1,212	Aug 31 04:01 PM
Shukla Rajiv	Executive Chairman	Aug 16 '23	Buy	3.74	1,112	4,154	1,112	Aug 31 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CTCX

Carmell Corp

Upgrade your FINVIZ experience